Bank Of New York Mellon Corp 89bio, Inc. Transaction History
Bank Of New York Mellon Corp
- $505 Trillion
- Q1 2025
A detailed history of Bank Of New York Mellon Corp transactions in 89bio, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 309,916 shares of ETNB stock, worth $3.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
309,916
Previous 248,156
24.89%
Holding current value
$3.05 Million
Previous $1.94 Billion
16.1%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ETNB
# of Institutions
208Shares Held
158MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$201 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$196 Million3.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.3MShares$141 Million4.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.32MShares$91.7 Million2.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$70.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $457M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...